Major Growth Driving Factors:
The growing geriatric population, increasing cases of multi-organ failure, rising number of organ transplants and organ donors, and growing initiatives to encourage organ donations are the major drivers for the growth of Organ Preservation Market.
Key Players:
The prominent players in the global organ preservation market are Paragonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr. Franz Köhler Chemie GmbH (Germany), Essential Pharmaceuticals, LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US), Shanghai Genext Medical Technology (China), Bridge to Life Limited (US), Waters Medical Systems (US), Preservation Solutions (US), Carnamedica (Poland), Transplant Biomedicals (Spain), Institut Georges Lopez (France), Global Transplant Solutions (US), Avionord (Italy), Organ Preservation Solutions (England), EBERS (Spain), S.A.L.F. (Italy), Biochefa (Poland), Vascular Perfusion Solutions, Inc. (US), and TX Innovations (Netherlands).
Projected Revenue Surge, Globally:
The organ preservation market is projected to reach USD 317 million by 2026 from USD 230 million in 2021, at a CAGR of 6.6%.
Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=261269915
The static cold storage segment accounted for the largest share of the organ preservation market in 2020
Based on technique, the organ preservation market is segmented into static cold storage, hypothermic machine perfusion and normothermic machine perfusion. In 2020, the static cold storage segment accounted for the largest share of the organ preservation market. This is the conventional method which is highly adopted making it the gold standard technique for organ preservation as the hypothermia induced in this technique results in reduced kinetics of metabolic activities from the donor organ. This technique is used to preserve the kidneys, liver, lungs, pancreas, and heart.
Recent Developments:
# In 2021, Paragonix Technologies launched the LIVERguard Donor Liver Preservation System in both the US and Europe. This strategy expanded Paragonixs’ product offerings and strengthened their geographic presence.
# In 2021, XVIVO Perfusion partnered with Contatti Medical (Brazil) to expand its business and gain access to a comprehensive network of transplantation centers in Latin America's largest country, Brazil.
# In 2021, Institut Georges Lopez (Igl) (France) expanded its presence by setting up a manufacturing facility in Cheyyar, Tamil Nadu, India, for manufacturing medical devices and solutions for flushing and preservation of organs.
# In 2021, Transmedics received premarket approval from the FDA for the OCS Heart System to be used with organs from donors after brain death (DBD).
# In 2020, Dr. Franz Köhler Chemie GmbH (Germany) entered into a joint venture with Melchers Group and CICEL (Germany) to establish Köhler Pharmaceuticals (Beijing) Ltd. in China for the distribution of Custodiol HTK solutions for cardiac and transplant surgery in the Chinese market.
Geographical Growth Dynamics:
Asia-Pacific is expected to register the highest CAGR in the organ preservation market
The Asia-Pacific market is expected to grow at the highest CAGR from 2021 to 2026. This can be attributed to factors such as the favorable government initiatives, increased awareness in people and increased organ donations. The universal government regulations in China and Japan (including for transplantation & related organ donation procedures), expanding healthcare infrastructures, increasing prevalence of chronic diseases, and growing medical tourism in RoAPAC countries will contribute to market growth in the APAC.
Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=261269915
Read More About the Related Reports:
Electrophysiology Market - Global Forecasts to 2027
Human Organoids Market - Global Forecasts to 2025
Biopreservation Market - Global Forecasts to 2025
Cardiac Monitoring Devices Market - Global Forecasts to 2025
Transplant Diagnostics Market - Global Forecasts to 2025
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
No comments:
Post a Comment